ABBOTT INDIA LTD.

NSE : ABBOTINDIABSE : 500488ISIN CODE : INE358A01014Industry : Pharmaceuticals & DrugsHouse : Abbott India - MNC
BSE7430.85132.9 (+1.82 %)
PREV CLOSE ( ) 7297.95
OPEN PRICE ( ) 7270.00
BID PRICE (QTY) 7430.85 (8)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 951
TODAY'S LOW / HIGH ( )7270.00 7450.00
52 WK LOW / HIGH ( )4035 7450
NSE7423.30120.1 (+1.64 %)
PREV CLOSE( ) 7303.20
OPEN PRICE ( ) 7300.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 7423.30 (8)
VOLUME 6583
TODAY'S LOW / HIGH( ) 7275.95 7448.00
52 WK LOW / HIGH ( )4001 7448
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 22-08 1944
Management Info
Munir Shaikh - Chairman Ambati Venu - Managing Director
Registered Office

Address Unit No. 3,Corporate Park,Sion Trombay Road,
Mumbai,
Maharashtra-400071

Phone 022- 67978888

Email investor.relations@abbott.co.in & webmaster@abbott.co.in

Website www.abbott.co.in

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
23Jun Abbott India informs about annual report
Pursuant to Regulation 34(1) of the Securities and Exchange Board of Ind..
23Jun Abbott India informs about newspaper c
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
15May Abbott India reports over 2-fold jump
Abbott India has reported results for fourth quarter and year ended Marc..
15May Abbott India zooms on reporting over 2
Abbott India is currently trading at Rs. 6725.65, up by 168.50 points or..
04May Corporate Action-Board to consider Di
In terms of Regulation 29 (1) (a) and (e) of the Securities and Exchange..
Financials
Rs. in Millions
QTR Mar 18 ANNUAL 18
Net Profit1000.84012.2
Gross Profit 1590.5 6214.8
Operating Profit 1652.26414.9
Net Sales 7883.633071.2
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 1478.55 (9.32%)
M.Cap (Rs. in Cr)3696.38
Piramal Enterprises (BSE)
 2602.35 (2.48%)
M.Cap (Rs. in Cr)46996.49
Sun Pharma Inds. (BSE)
 576.30 (3.91%)
M.Cap (Rs. in Cr)138273.07
Glaxosmithkline Phar (BSE)
 2801.00 (0.70%)
M.Cap (Rs. in Cr)23725.32
Dr. Reddys Lab (BSE)
 2334.95 (0.79%)
M.Cap (Rs. in Cr)38753.92
Shareholding Pattern
PROMOTERS 74.99%
NON-INSTITUTION 15.58%
MUTUAL FUNDS/UTI 5.32%
FI/BANKS/INSURANCE 0.69%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.